Publications & posters

SIRS 2025: Insights on Schizophrenia Research, From Rights Based Care to Digital Biomarkers

SIRS 2025: Insights on Schizophrenia Research, From Rights Based Care to Digital Biomarkers Michael Spilka, Sr. Clinical Scientist This year’s Schizophrenia International Research Society (SIRS) 2025 Congress in Chicago brought together leading scientists and researchers, exploring the latest advancements and ongoing challenges in understanding and addressing schizophrenia. Michael Spilka, PhD. shares his key insights from […]

SIRS 2025: Insights on Schizophrenia Research, From Rights Based Care to Digital Biomarkers Read More »

When to Use Standardised Assessments—And When You Might Need to Build Your Own

When to Use Standardised Assessments—And When You Might Need to Build Your Own Alex Kaula, Senior R&D Scientist Hello, I’m Alex Kaula, Senior R&D Scientist at Cambridge Cognition. If your research involves measuring cognitive function or clinical outcomes, you’ve likely faced this question: Should I use an established, validated assessment, or create a new one

When to Use Standardised Assessments—And When You Might Need to Build Your Own Read More »

Actigraphy and wearable sensor technologies to enhance assessment in health conditions

Actigraphy and wearable sensor technologies to enhance assessment in health conditions affecting motor function and behaviour Reflections from the 2025 Actigraph Digital Data Summit​ The 2025 ActiGraph Digital Data Summit in Pensacola, FL, provided a valuable environment for exploring the benefits and challenges of using actigraphy, and other wearable sensor technologies, to enhance assessment in

Actigraphy and wearable sensor technologies to enhance assessment in health conditions Read More »

ISCTM 2025

ISCTM | 21st Annual Scientific Meeting Washington, D.C., USA | 19-21 February 2025 About the ISCTM The International Society for CNS Clinical Trials and Methodology (ISCTM) is an independent multi-disciplinary organization devoted to promoting advances in, and dissemination of, clinical research methods related to development and use of CNS therapeutics. The ISCTM accomplishes this by

ISCTM 2025 Read More »

Enhancing Patient Outcomes in ADRD: Digital Measures that Matter

Enhancing Patient Outcomes in ADRD Digital Measures that Matter As the landscape for Alzheimer’s Disease and Related Dementias (ADRD) treatment evolves, it’s crucial to align clinical research with the experiences and needs of patients and their care partners. The Digital Medicine Society’s (DiMe) Core Digital Measures of ADRD conceptual model provides a patient-centred framework for

Enhancing Patient Outcomes in ADRD: Digital Measures that Matter Read More »

Exploring Innovation in Alzheimer’s Disease Research: Highlights from CTAD 2024

Exploring Innovation in Alzheimer’s Disease Research Highlights from CTAD 2024 17th Clinical Trials on Alzheimer’s Disease (CTAD) Madrid (Spain) October 29 – November 1, 2024 Last week, our team travelled to Madrid to participate in the 17th Clinical Trials on Alzheimer’s Disease (CTAD) conference, where we had the opportunity to present our latest research and

Exploring Innovation in Alzheimer’s Disease Research: Highlights from CTAD 2024 Read More »

Scroll to Top